These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 31315954)

  • 1. Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria.
    Brown-Elliott BA; Woods GL
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31315954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and drug susceptibility testing for nontuberculous mycobacteria.
    Huang WC; Yu MC; Huang YW
    J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S32-S41. PubMed ID: 32423573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Brown-Elliott BA; Rubio A; Wallace RJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.
    Brown-Elliott BA; Nash KA; Wallace RJ
    Clin Microbiol Rev; 2012 Jul; 25(3):545-82. PubMed ID: 22763637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification.
    Somoskovi A; Salfinger M
    Clin Lab Med; 2014 Jun; 34(2):271-95. PubMed ID: 24856528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
    Sharma M; Malhotra B; Khandelwal S
    Indian J Med Microbiol; 2021 Jul; 39(3):306-310. PubMed ID: 33846029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atypical mycobacteria and pulmonary involvement in infectious diseases].
    Camarena Miñana JJ; Pellicer RG
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():66-75. PubMed ID: 22305672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portuguese in vitro antibiotic susceptibilities favor current nontuberculous mycobacteria treatment guidelines.
    Durão V; Silva A; Macedo R; Durão P; Santos-Silva A; Duarte R
    Pulmonology; 2019; 25(3):162-167. PubMed ID: 30309821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
    Gitti Z; Mantadakis E; Maraki S; Samonis G
    Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid susceptibility testing for slowly growing nontuberculous mycobacteria using a colorimetric microbial viability assay based on the reduction of water-soluble tetrazolium WST-1.
    Tsukatani T; Suenaga H; Shiga M; Ikegami T; Ishiyama M; Ezoe T; Matsumoto K
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1965-73. PubMed ID: 26173690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
    Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
    Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medications and monitoring in nontuberculous mycobacteria infections.
    Egelund EF; Fennelly KP; Peloquin CA
    Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.
    Schwartz M; Fisher S; Story-Roller E; Lamichhane G; Parrish N
    Microb Drug Resist; 2018 Oct; 24(8):1191-1197. PubMed ID: 29368988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Culture, Identification, and Antimicrobial Susceptibility Testing of Pulmonary Nontuberculous Mycobacteria.
    Khare R; Brown-Elliott BA
    Clin Chest Med; 2023 Dec; 44(4):743-755. PubMed ID: 37890913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of standard strains of nontuberculous mycobacteria by microplate Alamar Blue assay.
    Li G; Lian LL; Wan L; Zhang J; Zhao X; Jiang Y; Zhao LL; Liu H; Wan K
    PLoS One; 2013; 8(12):e84065. PubMed ID: 24386332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.